| Associate Director Biostatistics |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
srp 05, 2024 |
| Senior Principal Data Scientist |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Data and Digital |
srp 05, 2024 |
| Senior Principal Pharmacometrics |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
srp 05, 2024 |
| BPA Planning Process, RLT |
Baarle Nassau |
Netherlands |
Finance |
Innovative Medicines |
Audit & Finance |
srp 05, 2024 |
| Assoc. Dir. DDIT Dev. GCO Tech. Design (Technical Business Analyst) |
Hyderabad (Office) |
India |
Operations |
CTS |
Technology Transformation |
srp 05, 2024 |
| Cardiologist Physician Scientist (Associate Director/Director) |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
srp 05, 2024 |
| MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
srp 05, 2024 |
| MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
srp 05, 2024 |
| MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
srp 05, 2024 |
| MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
srp 05, 2024 |
| MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
srp 05, 2024 |
| Product Specialist |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
srp 05, 2024 |
| MR |
Fuyang (Anhui Province) |
China |
International |
Innovative Medicines |
Sales |
srp 05, 2024 |
| (高级)医药代表 /(资深)产品专员 |
Qinnan (Guizhou Province) |
China |
International |
Innovative Medicines |
Sales |
srp 04, 2024 |
| Elektroniker (m/w/d) der Fachrichtung Betriebstechnik im Bereich Facility Management |
Wehr (Novartis Pharma Produktions GmbH) |
Germany |
Operations |
Innovative Medicines |
Technical Operations |
srp 02, 2024 |
| Mechaniker (m/w/d) im Bereich Facility Management |
Wehr (Novartis Pharma Produktions GmbH) |
Germany |
Operations |
Innovative Medicines |
Technical Operations |
srp 02, 2024 |
| Engineer (Multidiscipline) (m/w/d) im Bereich Facility Management |
Wehr (Novartis Pharma Produktions GmbH) |
Germany |
Operations |
Innovative Medicines |
Technical Operations |
srp 02, 2024 |
| Facility Expert (m/w/d) im Bereich Facility Management (80%) |
Wehr (Novartis Pharma Produktions GmbH) |
Germany |
Operations |
Innovative Medicines |
Technical Operations |
srp 02, 2024 |
| Sr. Automation Engineer |
Carlsbad |
USA |
Operations |
CTS |
Research & Development |
srp 02, 2024 |
| Senior Global Program Clinical Head, Oncology |
East Hanover |
USA |
Development |
Innovative Medicines |
Research & Development |
srp 02, 2024 |
| Sales Value Associate CDMX - Privado |
INSURGENTES |
Mexico |
International |
Innovative Medicines |
Sales |
srp 01, 2024 |
| Head Engineering (m/f/d) |
Puurs |
Belgium |
Operations |
Innovative Medicines |
Technical Operations |
srp 01, 2024 |
| Technical System Lead (Qualification) |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
čvc 31, 2024 |
| Pricing Manager |
New South Wales (NSW) |
Australia |
International |
Innovative Medicines |
Market Access |
čvc 31, 2024 |
| MS&T Expansion Lead RLT Sasayama |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Technical Operations |
čvc 31, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Third Party Risk Management Specialist |
Prague |
Czech Republic |
Operations |
CTS |
Procurement |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| County Executive |
Maoming (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Product Specialist |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 30, 2024 |
| Global Procurement Category Manager, Chemicals |
Prague |
Czech Republic |
Operations |
CTS |
Procurement |
čvc 29, 2024 |
| Clinical Development Medical Manager |
Shanghai (Shanghai) |
China |
Development |
Innovative Medicines |
Research & Development |
čvc 29, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| County Executive |
Xiaogan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |
| MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
čvc 28, 2024 |